Innovative Cancer Detection Avenda Health's flagship product, Unfold AI, significantly enhances cancer detection by revealing invisible tumors, enabling hospitals and clinics to improve treatment outcomes and patient quality of life. This positions the company as a key partner for healthcare providers seeking cutting-edge diagnostic solutions.

Recognition and Awards The company has received notable industry awards, including top Digital Health recognitions and awards at HLTH, which underscore its credibility and leadership in AI-driven healthcare innovations, making it an attractive partner for health systems aiming to adopt trusted digital solutions.

Recent Funding & Growth With recent venture funding of $3.5 million and revenue estimates between $1 million and $10 million, Avenda Health is experiencing growth and investment interest, presenting sales opportunities to early adopters and institutional clients looking to innovate in prostate cancer care.

Strategic Collaborations Partnerships with UCLA and innovative procedures like AI-Assisted Focal One Robotic HIFU demonstrate the company's active engagement in research and clinical trials, offering opportunities to collaborate with forward-thinking healthcare organizations seeking to enhance their oncological services.

Market Focus on Oncology Specializing in personalized prostate cancer care, Avenda Health appeals to urology and oncology specialists, providing a niche for targeting healthcare providers seeking to incorporate advanced AI technologies into their cancer treatment protocols.